Cutaneous Lymphoma Foundation Offers Support, Information

I am always excited to find new resources to tell you about and this blogpost should be filed in the “I can’t believe I missed this one” category.
You may have noticed we don’t have any info on our site on Cutaneous T-cell lymphoma, or it may not be a term with which you are familiar. We’ll start to rectify that immediately. Cutaneous lymphoma is a general term for many lymphomas of the skin including:
• cutaneous T-cell lymphoma
• mycosis fungoides
• Sézary syndrome
• cutaneous anaplastic large cell lymphoma
• adult T-cell leukemia/lymphoma
• peripheral T-cell lymphoma
• lymphomatoid granulomatosis
• granulomatous slack skin disease
• B-cell lymphoma
• pagetoid reticulosis
There is a greater frequency among men than women and it is more common after the age of 50. There are approximately 16,000 to 20,000 cases across the United States. Treatment varies, and many patients live normal lives while they treat their disease and some are able to remain in remission for long periods of time.
If you are interested in learning more, or you or a loved one needs information, the absolute best place to go is the Cutaneous Lymphoma Foundation. They offer the very latest on research developments with educational seminars, patient assistance programs, local gatherings, a listserv, and other forms of support.

Cutaneous Lymphoma Foundation
PO Box 374
Birmingham, MI 48012
(248) 644-9014
http://www.clfoundation.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap